Type 1 Diabetes: Clinical Trials

12 trials for Type 1 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 12
Phase 14Unknown 4
Phase 31Unknown 1

Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
Semaglutide weekly injection - Type 1 Diabetes
Phase 1 / Phase 2UnknownMinistry of Health, Saudi Arabia1202024-01-012023-09-28
A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes
Hybrid automated Lyumjev delivery system with carbohydrate counting, Hybrid automated Lyumjev delivery system with meal size estimation, Fully automated Lyumjev delivery system with meal detection - Diabetes Mellitus, Type 1, Type 1 Diabetes
Phase 2UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre122023-12-202024-03-29
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
68Ga-NODAGA-Exendin-4 - Type 1 Diabetes
Phase 2UnknownRadboud University Medical Center202023-02-232023-04-04
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Victoza®, Placebo - Type 1 Diabetes
Phase 2UnknownUniversity of Oulu422015-12-012022-01-25
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Liraglutide, Exenatide, Liquid meal test - Type 1 Diabetes
Phase 2 / Phase 3UnknownHvidovre University Hospital102015-07-012015-10-22
Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Ustekinumab - Type 1 Diabetes
Phase 1 / Phase 2UnknownUniversity of British Columbia202015-03-012016-05-25
Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy
Stem Cell Educator - Type 1 Diabetes
Phase 1 / Phase 2UnknownThrone Biotechnologies Inc.202013-11-012019-02-05
Closing the Loop in Young Children With Type 1 Diabetes
Overnight closed-loop insulin delivery - Type 1 Diabetes
Phase 2UnknownDaniela Elleri122012-12-012013-04-04
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes
Intradermal injection, Subcutaneous injection - Type 1 Diabetes
Phase 2UnknownMassachusetts General Hospital202012-08-012016-09-07
Bet Cell Therapy in Diabetes Type 1
Transplantation of encapsulated beta cells. - Type 1 Diabetes
Phase 2UnknownUniversitair Ziekenhuis Brussel102011-05-012013-12-30
Stem Cell Educator Therapy in Type 1 Diabetes
Stem Cell Educator - Type 1 Diabetes
Phase 2UnknownThrone Biotechnologies Inc.1002010-09-012019-02-05
Beta Cell Function in (Pre) Type 1 Diabetes
glucose 20% - Type 1 Diabetes
Phase 1 / Phase 2UnknownUniversitair Ziekenhuis Brussel2002006-10-012013-12-30

Narrower conditions

Diabetes Mellitus, Type 1 (12)  ·  Autoimmune Diseases (1)  ·  Diabetes Mellitus (1)  ·  Insulin Resistance (1)

Broader conditions

Endocrine System Diseases (12)  ·  Glucose Metabolism Disorders (12)  ·  Immune System Diseases (12)  ·  Metabolic Diseases (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Autoimmune Diseases (11)  ·  Diabetes Mellitus (11)  ·  Hyperinsulinism (1)

Interventions

Liraglutide (2)  ·  (Nle14,Lys40(Ahx-NODAGA-68Ga)NH2)exendin-4 (1)  ·  Exenatide (1)  ·  Injections, Intradermal (1)  ·  Injections, Subcutaneous (1)  ·  Ustekinumab (1)

Sponsors

Throne Biotechnologies Inc. (2)  ·  Universitair Ziekenhuis Brussel (2)  ·  Daniela Elleri (1)  ·  Hvidovre University Hospital (1)  ·  Massachusetts General Hospital (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Ministry of Health, Saudi Arabia (1)  ·  Radboud University Medical Center (1)  ·  University of British Columbia (1)  ·  University of Oulu (1)

Countries

Belgium (2)  ·  Canada (2)  ·  China (2)  ·  Finland (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ahmad Haidar, Ph.D. (1)  ·  Annika Sun, MSc (1)  ·  Ashish Marwaha, BMBCh PhD (1)  ·  Bart Keymeulen, MD PhD (1)  ·  Jan Dutz, MD FRCPC (1)  ·  Laurent Legault, M.D. (1)  ·  Martin Gotthardt, MD, Prof. (1)  ·  Melissa-Rosina Pasqua, M.D. (1)  ·  Michael Tsoukas, M.D. (1)  ·  Riitta Veijola, MD (1)  ·  Roman Hovorka, PhD (1)  ·  Steven J Russell, MD, PhD (1)  ·  Yong Zhao, MD, PhD (1)  ·  Yong Zhao, MD,PhD (1)  ·  Zhiguang Zhou, Md,PhD (1)

Results publications

PMID 23620058, PMID 25512874, PMID 25537835, PMID 26844283, PMID 27048952, PMID 35072168, PMID 35797241, PMID 39206389, PMID 42267693

NIH funding

2014 (1)